Skip to Content
Print Share

AMNEAL 506 (Indomethacin Extended Release 75 mg)

Pill with imprint AMNEAL 506 is Blue / Clear, Capsule-shape and has been identified as Indomethacin Extended Release 75 mg. It is supplied by Amneal Pharmaceuticals.

Indomethacin is used in the treatment of back pain; ankylosing spondylitis; bursitis; bartter syndrome; cluster headaches and belongs to the drug class Nonsteroidal anti-inflammatory drugs. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AMNEAL 506

Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release 75 mg AMNEAL 506

Indomethacin Extended Release

Imprint
AMNEAL 506
Strength
75 mg
Color
Blue / Clear
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals
National Drug Code (NDC)
65162-0506
Inactive Ingredients
ammonia, corn starch, ferrosoferric oxide, butyl alcohol, FD&C Blue No. 1, FD&C Green No. 3, FD&C Yellow No. 5, FD&C Red No. 40, gelatin, isopropyl alcohol, lactose monohydrate, potassium hydroxide, povidone, propylene glycol, shellac, sucrose, magnesium silicate

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer